3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Healthy Volunteer: new trials by email Literature Review of Healthy Volunteer trials Research Report on Healthy Volunteer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LC-Plasma on Immune Response and Reducing Symptoms of Upper Respiratory Infectious Diseases LC-Plasma, Placebo - Healthy Volunteer, Immune Response | Phase 3 | Completed | RDC Clinical Pty Ltd | 241 | 2025-04-29 | 2025-11-18 |
| LC-Plasma for Preventing URTIs and Reducing Symptoms LC-Plasma, Placebo - Healthy Volunteer, URTI | Phase 3 | Completed | RDC Clinical Pty Ltd | 637 | 2025-03-28 | 2026-03-06 |
| Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life Nirsevimab - RSV Immunization, Healthy Volunteer | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 8057 | 2022-08-08 | 2025-10-09 |
nirsevimab (1)
RDC Clinical Pty Ltd (2) · Sanofi Pasteur, a Sanofi Company (1)
Australia (2) · France (1) · Germany (1) · United Kingdom (1)
Osamu Kanauchi (2) · Yusuke Ushida (2)